Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study.

Saved in:
Bibliographic Details
Title: Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study.
Authors: Lipton, Richard B.1 (AUTHOR), Mosher, Linda2 (AUTHOR), Fountaine, Robert J.2 (AUTHOR) robert.j.fountaine@pfizer.com
Source: Pain & Therapy. Feb2026, Vol. 15 Issue 1, p325-340. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 190887611
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Lipton%2C+Richard+B%2E%22">Lipton, Richard B.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mosher%2C+Linda%22">Mosher, Linda</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fountaine%2C+Robert+J%2E%22">Fountaine, Robert J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> robert.j.fountaine@pfizer.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Pain+%26+Therapy%22">Pain & Therapy</searchLink>. Feb2026, Vol. 15 Issue 1, p325-340. 16p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=190887611
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40122-025-00800-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 16
        StartPage: 325
    Titles:
      – TitleFull: Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lipton, Richard B.
      – PersonEntity:
          Name:
            NameFull: Mosher, Linda
      – PersonEntity:
          Name:
            NameFull: Fountaine, Robert J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 21938237
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Pain & Therapy
              Type: main
ResultId 1